Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male rats
- 20 February 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 49 (2), 513-518
- https://doi.org/10.1016/j.jpba.2008.11.004
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Identification of cytochrome P450 enzymes responsible forN-dealkylation of a new oral erectogenic, mirodenafilXenobiotica, 2008
- Looking to the Future for Erectile Dysfunction TherapiesDrugs, 2008
- Pharmacokinetics and tissue distribution of a novel PDE5 inhibitor, SK-3530, in ratsActa Pharmacologica Sinica, 2007
- Metabolism and excretion of 5‐ethyl‐2‐{5‐[4‐(2‐hydroxyethyl)piperazine‐1‐sulfonyl]‐2‐propoxyphenyl}‐7‐propyl‐3,5‐dihydropyrrolo[3,2‐d]‐pyrimidin‐4‐one (SK3530) in ratsRapid Communications in Mass Spectrometry, 2007
- Pharmacokinetics of sildenafil after intravenous and oral administration in rats: Hepatic and intestinal first-pass effectsInternational Journal of Pharmaceutics, 2006
- Simultaneous assay of sildenafil and desmethylsildenafil in human plasma using liquid chromatography–tandem mass spectrometry on silica column with aqueous–organic mobile phaseJournal of Chromatography B, 2002
- Identification of the cytochrome P450 enzymes involved in the N‐demethylation of sildenafilBritish Journal of Clinical Pharmacology, 2001
- Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and manXenobiotica, 1999